(Q37948993)

25 August 2017

Nanotherapeutics for Alzheimer's disease (AD): Past, present and future (English)

1 reference

25 August 2017

0 references

3

1 reference

25 August 2017

5

1 reference

25 August 2017

Mohammad Fazil

1

1 reference

25 August 2017

Shadab

series ordinal

2

1 reference

25 August 2017

Jasjeet K Sahni

series ordinal

4

1 reference

25 August 2017

language of work or name

1 reference

25 October 2011

1 reference

Journal of Drug Targeting

25 August 2017

1 reference

25 August 2017

20

1 reference

25 August 2017

2

1 reference

25 August 2017

97-113

1 reference

Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases

25 August 2017

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Development of a smart nano-vehicle to target cerebrovascular amyloid deposits and brain parenchymal plaques observed in Alzheimer's disease and cerebral amyloid angiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Strategy for effective brain drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Significant entry of tubocurarine into the brain of rats by adsorption to polysorbate 80-coated polybutylcyanoacrylate nanoparticles: an in situ brain perfusion study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Neuroprotective mechanism conferred by 17beta-estradiol on the biochemical basis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Intramuscular desferrioxamine in patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Resveratrol--a boon for treating Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Physiological and metabolic functions of melatonin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Brain ferritin iron as a risk factor for age at onset in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Iron: a pathological mediator of Alzheimer disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Promotion of transition metal-induced reactive oxygen species formation by beta-amyloid

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Toxicological hazards of inhaled nanoparticles--potential implications for drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Molecular tools to study melatonin pathways and actions.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Electrical resistance across the blood-brain barrier in anaesthetized rats: a developmental study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

BACE1 is the major beta-secretase for generation of Abeta peptides by neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Iron: the Redox-active center of oxidative stress in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Differential distribution of ferulic acid to the major plasma constituents in relation to its potential as an antioxidant

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Future prospects of nanoparticles on brain targeted drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Rare earth nanoparticles prevent retinal degeneration induced by intracellular peroxides

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Quantifying drug release from PLGA nanoparticulates

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Galantamine, a cholinesterase inhibitor that allosterically modulates nicotinic receptors: effects on the course of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

A nanoparticulate drug-delivery system for rivastigmine: physico-chemical and in vitro biological characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Therapeutic treatments for Alzheimer's disease based on metal bioavailability

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Effects of chelators on iron uptake and release by the brain in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Novel D-penicillamine carrying nanoparticles for metal chelation therapy in Alzheimer's and other CNS diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Influence of particle size and dissolution conditions on the degradation properties of polylactide-co-glycolide particles

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Nanoparticles in cellular drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Treatment options in Alzheimer's disease: maximizing benefit, managing expectations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Pharmacokinetic profiles of current therapies for Alzheimer's disease: implications for switching to galantamine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Effects of emulsifiers on the controlled release of paclitaxel (Taxol) from nanospheres of biodegradable polymers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Paclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

The cholinergic hypothesis of Alzheimer's disease: a review of progress

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Ketoprofen-poly(D,L-lactic-co-glycolic acid) microspheres: influence of manufacturing parameters and type of polymer on the release characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Brain delivery of vasoactive intestinal peptide enhanced with the nanoparticles conjugated with wheat germ agglutinin following intranasal administration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Long-term shelf stability of amphiphilic beta-cyclodextrin nanosphere suspensions monitored by dynamic light scattering and cryo-transmission electron microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

From Vasoactive Intestinal Peptide (VIP) Through Activity-Dependent Neuroprotective Protein (ADNP) to NAP: A View of Neuroprotection and Cell Division

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Significant transport of doxorubicin into the brain with polysorbate 80-coated nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Electron microscopic analysis of nanoparticles delivering thioflavin-T after intrahippocampal injection in mouse: implications for targeting beta-amyloid in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Core-shell type of nanoparticles composed of poly[(n-butyl cyanoacrylate)-co-(2-octyl cyanoacrylate)] copolymers for drug delivery application: synthesis, characterization and in vitro degradation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Protective effect of resveratrol on beta-amyloid-induced oxidative PC12 cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Rivastigmine-loaded PLGA and PBCA nanoparticles: preparation, optimization, characterization, in vitro and pharmacodynamic studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Apolipoprotein E LDL receptor-binding domain-containing high-density lipoprotein: a nanovehicle to transport curcumin, an antioxidant and anti-amyloid bioflavonoid

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Toxicity and tissue distribution of magnetic nanoparticles in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Targeting small Abeta oligomers: the solution to an Alzheimer's disease conundrum?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Role of nanotechnology in targeted drug delivery and imaging: a concise review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Nanoparticulate systems for brain delivery of drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

A predictor for side effects in patients with Alzheimer's disease treated with deferoxamine mesylate.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Quinoline-n-butylcyanoacrylate-based nanoparticles for brain targeting for the diagnosis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Penetration of titanium dioxide microparticles in a sunscreen formulation into the horny layer and the follicular orifice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

The protection of long chain polyunsaturated fatty acids by melatonin during nonenzymatic lipid peroxidation of rat liver microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Neurotrophic and neuroprotective actions of estrogens and their therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Nanoparticle and other metal chelation therapeutics in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Acyclonucleoside iron chelators of 1-(2-hydroxyethoxy)methyl-2-alkyl-3-hydroxy-4-pyridinones: potential oral iron chelation therapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Nanoparticle-chelator conjugates as inhibitors of amyloid-beta aggregation and neurotoxicity: a novel therapeutic approach for Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Metal chelators coupled with nanoparticles as potential therapeutic agents for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Nanoparticle technology for drug delivery across the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Resveratrol-loaded polymeric micelles protect cells from Abeta-induced oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Functionalization of gold nanoparticles with amino acid, beta-amyloid peptides and fragment.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Donepezil for cognitive impairment in Parkinson's disease: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Development and evaluation of polymer nanoparticles for oral delivery of estradiol to rat brain in a model of Alzheimer's pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Development of curcuminoids loaded poly(butyl) cyanoacrylate nanoparticles: Physicochemical characterization and stability study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Drug delivery to the brain--realization by novel drug carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Memory impairment and neuronal dysfunction induced by beta-amyloid protein in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Development of PEGylated PLGA nanoparticle for controlled and sustained drug delivery in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

An introduction to the free radical hypothesis in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Curcumin has potent anti-amyloidogenic effects for Alzheimer's beta-amyloid fibrils in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Blood-brain barrier drug targeting: the future of brain drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Various drug delivery approaches to the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Progress in drug delivery to the central nervous system by the prodrug approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Protective actions of sex steroid hormones in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Therapeutic potential of controlled drug delivery systems in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Direct imaging of single-walled carbon nanotubes in cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Multiple antioxidants in the prevention and treatment of Alzheimer disease: analysis of biologic rationale

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Emerging role of polyphenolic compounds in the treatment of neurodegenerative diseases: a review of their intracellular targets

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Regional cerebrovascular permeability to [14C]sucrose after osmotic opening of the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Galantamine in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Treatment with an acetylcholinesterase inhibitor in Alzheimer patients modulates the expression and production of the pro-inflammatory and anti-inflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Treatment of Alzheimer's disease with clioquinol

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Reactive oxygen and nitrogen species and cellular and organismal decline: amelioration with melatonin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Green tea epigallocatechin-3-gallate (EGCG) reduces beta-amyloid mediated cognitive impairment and modulates tau pathology in Alzheimer transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

A potential role of the curry spice curcumin in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Metal-protein attenuating compounds and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Neurotherapeutic applications of nanoparticles in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Pathway across blood-brain barrier opened by the bradykinin agonist, RMP-7.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Randomization of amyloid-β-peptide(1-42) conformation by sulfonated and sulfated nanoparticles reduces aggregation and cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Chemistry and biochemistry of oxidative stress in neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Protective properties of melatonin-loaded nanoparticles against lipid peroxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Incorporation in polymeric nanocapsules improves the antioxidant effect of melatonin against lipid peroxidation in mice brain and liver

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Nanoparticle technology for delivery of drugs across the blood-brain barrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

The role of iron in beta amyloid toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

In vivo protein transduction: delivery of a biologically active protein into the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Nanoparticles aggravate heat stress induced cognitive deficits, blood-brain barrier disruption, edema formation and brain pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Blood-cerebrospinal fluid barrier in hyperthermia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Chronic treatment with trans resveratrol prevents intracerebroventricular streptozotocin induced cognitive impairment and oxidative stress in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Curcumin: the story so far.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Thioflavins released from nanoparticles target fibrillar amyloid beta in the hippocampus of APP/PS1 transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Synthesis of fluorescent-maghemite nanoparticles as multimodal imaging agents for amyloid-beta fibrils detection and removal by a magnetic field

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Nanolipidic particles improve the bioavailability and alpha-secretase inducing ability of epigallocatechin-3-gallate (EGCG) for the treatment of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Amyloid-beta and tau serve antioxidant functions in the aging and Alzheimer brain

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Radical AGEing in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Nerve growth factor signaling, neuroprotection, and neural repair

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Amyloid-beta associated with chitosan nano-carrier has favorable immunogenicity and permeates the BBB.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Specific role of polysorbate 80 coating on the targeting of nanoparticles to the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Therapeutic potential of pyruvate therapy for mitochondrial diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Challenges and opportunities in CNS delivery of therapeutics for neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Nanosized cationic hydrogels for drug delivery: preparation, properties and interactions with cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Preparation of estradiol chitosan nanoparticles for improving nasal absorption and brain targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Comparative pulmonary toxicity assessment of single-wall carbon nanotubes in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Poly(n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Chitosan nanoparticles as a new delivery system for the anti-Alzheimer drug tacrine.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Non-enzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid beta-peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Pharmacological and toxicological target organelles and safe use of single-walled carbon nanotubes as drug carriers in treating Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Iron, brain ageing and neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

The chemical species of aluminum influences its paracellular flux across and uptake into Caco-2 cells, a model of gastrointestinal absorption.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

2 Clinically Useful Chelators of Tripositive Elements

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Galantamine--a novel cholinergic drug with a unique dual mode of action for the treatment of patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

In Situ Oxidative Catalysis by Neurofibrillary Tangles and Senile Plaques in Alzheimer’s Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

Development of a nanoprecipitation method intended for the entrapment of hydrophilic drugs into nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.607499

10.3109/1061186X.2011.607499

21 January 2018

Identifiers

DOI

1 reference

25 August 2017

1 reference